Monday, June 15, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1057 of 1,261
  1. US 7388089

    Anti-arthropod vector vaccines method of selecting and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  2. US 7388074

    Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  3. US 7388017

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  4. US 7388002

    Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

    BioCryst Pharmaceuticals, Inc. · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  5. US 7387881

    Detection and treatment of cancers of the liver

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  6. US 7388071

    Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response

    The Regents of the University of California · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  7. US 7387896

    MicroRNA vectors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  8. US 7388088

    High affinity human antibodies to tumor antigens

    The Regents of the University of California · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  9. US 7384921

    Polymorphic forms of 6-11 bicyclic ketolide derivatives

    Enanta Pharmaceuticals, Inc. · Granted Jun 10, 2008 · Expires Jun 5, 2028

    granted
  10. US 7384909

    Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Jun 10, 2008 · Expires Jun 5, 2028

    granted
  11. US 7384623

    High energy phototherapeutic agents

    Provectus Pharmatech, Inc. · Granted Jun 10, 2008 · Expires Jun 5, 2028

    granted
  12. US 7384978

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Jun 10, 2008 · Expires Jun 5, 2028

    granted
  13. EP 1926473

    ANTIMIKROBIELLE ZUBEREITUNGEN MIT EINEM IN LIPOSOMEN VERKAPSELTEN GEHALT AN OCTENIDINDIHYDROCHLORID

    AIR LIQUIDE SANTE INT [FR] · Granted Jun 4, 2008 · Expires May 30, 2028

    granted
  14. US 7381825

    Histone deacetylase inhibitors

    Takeda San Diego, Inc. · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  15. US 7381405

    Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  16. US 7381744

    Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  17. US 7381404

    Treatment for dry macular degeneration

    The Regents of the University of California · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  18. US 7381699

    Reagents and methods for smooth muscle therapies

    THE ARIZONA BOARD OF REGENTS · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  19. US 7381827

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  20. US 7381748

    Compounds and related methods for inhibition of gamma-aminobutyric acid aminotransferase

    Northwestern University · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  21. US 7381408

    Methods for chemically synthesizing immunoglobulin chimeric proteins

    Syntonix Pharmaceuticals, Inc. · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  22. US 7378257

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted May 27, 2008 · Expires May 22, 2028

    granted
  23. US 7378108

    Percutaneous absorption preparation of compound having angiotensin II antagonistic activity

    Takeda Pharmaceutical Company Limited · Granted May 27, 2008 · Expires May 22, 2028

    granted
  24. US 7378273

    Expression vectors

    Gala Design, Inc. · Granted May 27, 2008 · Expires May 22, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.